Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute Exacerbation

NCT01848743 is registered in ClinicalTrials.gov with Kaohsiung Veterans General Hospital. as lead sponsor.

NCT NCT01848743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01848743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute Exacerbation
Lead sponsor
Kaohsiung Veterans General Hospital.
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2013
Completion date
October 31, 2016
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hbv with severe exacerbation